In conclusion, this study demonstrates that components of the TIMM8A-TIMM13 complex exhibit elevated expression and potentially contribute to disease progression and poor outcomes in lung cancer patients through upregulation of CCND1 and CDK6. Here, CDK6 is linked to lung cancer.